Skip to main content
Veterinary Medicines

Enrocill Flavour tablets 50 mg for dogs and cats

Authorised
  • Enrofloxacin

Product identification

Medicine name:
Enrocill Flavour tablets 50 mg for dogs and cats
Enro-Sleecol Flavour 50 mg
Active substance:
  • Enrofloxacin
Target species:
  • Dog
  • Cat
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Enrofloxacin
    50.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01MA90
Authorisation status:
  • Valid
Authorised in:
  • Germany
Package description:
  • box containing 100 tablets (10 blister)
  • box containing 10 tablets (1 blister)

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • KRKA tovarna zdravil d.d. Novo mesto
Marketing authorisation date:
Manufacturing sites for batch release:
  • KRKA tovarna zdravil d.d. Novo mesto
  • Krka-Farma d.o.o.
Responsible authority:
  • Federal Office Of Consumer Protection And Food Safety
Authorisation number:
  • 402155.00.00
Date of authorisation status change:
Reference member state:
  • Spain
Procedure number:
  • ES/V/0207/002
Concerned member states:
  • Germany
  • Greece
  • Portugal

Documents

Labelling

English (PDF)
Published on: 11/04/2023
Download

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 7/02/2025

eu-PUAR-enrocill-flavour-tablets-50-mg-for-dogs-and-cats-en.pdf

English (PDF)
Published on: 11/04/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."